About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 864 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 864 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 461-480 of 864 trials

Active not recruitingPivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate CancerA prospective, multi-center, single-arm study, planned in 150 patients.NCT02766543·Los Angeles, California and 13 others TerminatedA 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate CancerA Phase 2, 2 part trial to evaluate the safety and efficacy of galeterone in castration resistant prostate cancer (CRPC) patients.NCT01709734·Los Angeles, California and 22 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedAn Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid TumorsTo determine the feasibility and safety of administering YM155 in combination with docetaxelNCT00514267·San Antonio, Texas

RecruitingA Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical ProstatectomyTo learn about the safety and effects of a drug called REGN5678 when it is given to patients with high-risk prostate cancer.NCT06085664·Houston, Texas

CompletedThe Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation TherapyThe purpose of this study is to compare the effect of an investigational drug used intravenously and placebo administered every three months for one year, on bone loss associated…NCT00063609·Birmingham, Alabama and 43 others

TerminatedRegistry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging EvaluationsThe purpose of this observational research registry is to understand the real-world use of Illuccix PET/CT in prostate cancer, and how results from this testing impact patient's…NCT06655064·Fresno, California and 8 others

RecruitingTesting the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialThis phase III trial compares the effect of adding docetaxel to hormonal therapy and apalutamide versus hormonal therapy and apalutamide alone in treating patients with prostate…NCT06931340·Tucson, Arizona and 213 others

RecruitingStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid TumorsThis is a Phase 1/2A, open label, multicenter, nonrandomized, multiple dose, safety, tolerability, pharmacokinetic and pharmacodynamic study of PF-07220060 administered as a…NCT04557449·Los Angeles, California and 38 others

CompletedCyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryThe purpose of this study is to investigate the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer and to evaluate the effects of this…NCT00643617·Mobile, Alabama and 17 others

CompletedA Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate CancerThe purpose of this study is to evaluate the efficacy of TAK 385 for achieving and maintaining testosterone suppression (\<50 ng/dL).NCT02083185·Birmingham, Alabama and 22 others

CompletedNerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate CancerRATIONALE: Nerve-sparing radical prostatectomy with nerve grafting followed by standard therapies for erectile dysfunction may be effective in helping patients with prostate…NCT00080808·Houston, Texas

CompletedStudy to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate CancerThe purpose of the study is to determine whether lenalidomide is safe and effective for use in combination with docetaxel and prednisone for the treatment of subjects with…NCT00988208·Phoenix, Arizona and 209 others

CompletedChemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00002855·Houston, Texas

RecruitingSafety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate CancerThere are many treatment options for men with various stages of prostate cancer. Some treatments work well for a while but can cause medical problems in some men.NCT05997615·Duarte, California and 25 others

CompletedINCB106385 Alone or in Combination With Immunotherapy in Advanced Solid TumorsThis is a multicenter, open-label, dose-escalation/dose-expansion Phase 1 clinical study to investigate the safety, tolerability, PK profile, pharmacodynamics, and preliminary…NCT04580485·West Hollywood, California and 26 others

CompletedA Phase I Study of SOR-C13 in Patients With Advanced Solid TumorsThis phase I trial studies the side effects and best dose of SOR-C13 in treating patients with solid tumors that have spread to other places in the body (advanced) and does not…NCT03784677·Houston, Texas

CompletedUrology San Antonio MRI/MicroUS ComparisonThis study compares micro-ultrasound image targeted prostate biopsy with multi-parametric MRI targeted biopsy in men indicated for prostate biopsy due to suspicion of prostate…NCT03762616·San Antonio, Texas

Active not recruitingA Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate CancerMen with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this…NCT05027477·Chandler, Arizona and 21 others

CompletedTisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid TumorsThe purpose of the trial is to establish the tolerability of tisotumab vedotin (HuMax-TF-ADC) dosed three times every four weeks (3q4wk) in a mixed population of patients with…NCT02552121·Houston, Texas and 15 others

WithdrawnRadiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After SurgeryRATIONALE: Radiation therapy uses high energy x-rays to kill tumor cells.NCT01079793·Dallas, Texas

PreviousPage 24 of 44Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma